Skip to main content
. Author manuscript; available in PMC: 2020 Dec 5.
Published in final edited form as: Lancet HIV. 2019 Dec 6:S2352-3018(19)30337-6. doi: 10.1016/S2352-3018(19)30337-6

Figure 4:

Figure 4:

Kaplan Meier curves of time to virologic failure (≥400 copies/µL) in the OLA-Guided Therapy (a) and SOC participants (b) by HIV drug-resistance mutation frequency, and drug resistance mutation frequencies by arm (c-e)

*The graph indicates the number of participants at risk at each time point and the number experiencing virologic failure in parenthesis.